ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
The biotech firm Ruga Corp. has changed its name to Aravive Biologics and moved from Palo Alto, Calif., to Houston after receiving a $20 million grant from the Cancer Prevention & Research Institute of Texas (CPRIT). The product of a 2007 state constitutional amendment, CPRIT has to date awarded $1.7 billion to Texas researchers. Aravive will be based at the Texas Medical Center, where it will develop Aravive-S6, a fusion protein designed to block a signaling pathway active in acute myelogenous leukemia.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter